Abstract
Sham surgery is a controversial and rarely used component of randomised clinical trials evaluating surgical interventions. The recent use of sham surgery in trials evaluating efficacy of intracerebral fetal tissue grafts in Parkinson's disease has highlighted the ethical concerns associated with sham surgery controls. Macklin, and Dekkers and Boer argue vigorously against use of sham surgery controls. Macklin presents a broad argument against sham surgery controls while Dekkers and Boer present a narrower argument that sham surgery is unnecessary in the specific setting of fetal tissue engraftment for Parkinson's disease. I defend sham surgery controls against both these criticisms. Appropriate clinical trial design, sometimes including sham surgery, is needed to ensure that false positive trial results do not occur and endanger public safety. Results of a completed trial of fetal tissue grafting for Parkinson's disease are used to illustrate the potential benefits of, and problems associated with, sham surgery controls. Sham surgery controls, however, should be employed only when absolutely necessary. I suggest criteria for appropriate use of sham surgery controls.
Full Text
The Full Text of this article is available as a PDF (114.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BEECHER H. K. Surgery as placebo. A quantitative study of bias. JAMA. 1961 Jul 1;176:1102–1107. doi: 10.1001/jama.1961.63040260007008. [DOI] [PubMed] [Google Scholar]
- COBB L. A., THOMAS G. I., DILLARD D. H., MERENDINO K. A., BRUCE R. A. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959 May 28;260(22):1115–1118. doi: 10.1056/NEJM195905282602204. [DOI] [PubMed] [Google Scholar]
- Dekkers W., Boer G. Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable? J Med Ethics. 2001 Jun;27(3):151–156. doi: 10.1136/jme.27.3.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emanuel E. J., Wendler D., Grady C. What makes clinical research ethical? JAMA. 2000 May 24;283(20):2701–2711. doi: 10.1001/jama.283.20.2701. [DOI] [PubMed] [Google Scholar]
- Freed C. R., Greene P. E., Breeze R. E., Tsai W. Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J. Q. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001 Mar 8;344(10):710–719. doi: 10.1056/NEJM200103083441002. [DOI] [PubMed] [Google Scholar]
- Freeman T. B., Vawter D. E., Leaverton P. E., Godbold J. H., Hauser R. A., Goetz C. G., Olanow C. W. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med. 1999 Sep 23;341(13):988–992. doi: 10.1056/NEJM199909233411311. [DOI] [PubMed] [Google Scholar]
- Goetz C. G., Leurgans S., Raman R., Stebbins G. T. Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 8;54(3):710–714. doi: 10.1212/wnl.54.3.710. [DOI] [PubMed] [Google Scholar]
- Hróbjartsson A., Gøtzsche P. C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001 May 24;344(21):1594–1602. doi: 10.1056/NEJM200105243442106. [DOI] [PubMed] [Google Scholar]
- Joffe S., Cook E. F., Cleary P. D., Clark J. W., Weeks J. C. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001 Nov 24;358(9295):1772–1777. doi: 10.1016/S0140-6736(01)06805-2. [DOI] [PubMed] [Google Scholar]
- Macklin R. The ethical problems with sham surgery in clinical research. N Engl J Med. 1999 Sep 23;341(13):992–996. doi: 10.1056/NEJM199909233411312. [DOI] [PubMed] [Google Scholar]
- Moseley J. B., Jr, Wray N. P., Kuykendall D., Willis K., Landon G. Arthroscopic treatment of osteoarthritis of the knee: a prospective, randomized, placebo-controlled trial. Results of a pilot study. Am J Sports Med. 1996 Jan-Feb;24(1):28–34. doi: 10.1177/036354659602400106. [DOI] [PubMed] [Google Scholar]
- Shetty N., Friedman J. H., Kieburtz K., Marshall F. J., Oakes D. The placebo response in Parkinson's disease. Parkinson Study Group. Clin Neuropharmacol. 1999 Jul-Aug;22(4):207–212. [PubMed] [Google Scholar]